how to transition off semaglutide Taper Safely Switching from semaglutide to tirzepatide

Food and Drug Administration, January 2025

Weight loss consultation Personalized consultation with a licensed doctor who can assess your individual needs and prescribe a GLP-1 medication, if appropriate

(2021) Cell Rep 36 : 109374-109374 PubMed: 34260945 Search on PubMed DOI: Primary Citation Related Structures: 7KI0, 7KI1 PubMed Abstract: The glucagon-like peptide-1 receptor (GLP-1R) regulates insulin secretion, carbohydrate metabolism, and appetite and is an important target for treatment of type 2 diabetes and obesity

The safety and effectiveness of combining semaglutide with other ingredients has not been established

Had no side effects